WO1996040175A1 - Stromal cell-based three-dimensional culture system for forming tubes, tendons, ligaments and corrective structures - Google Patents
Stromal cell-based three-dimensional culture system for forming tubes, tendons, ligaments and corrective structures Download PDFInfo
- Publication number
- WO1996040175A1 WO1996040175A1 PCT/US1996/008425 US9608425W WO9640175A1 WO 1996040175 A1 WO1996040175 A1 WO 1996040175A1 US 9608425 W US9608425 W US 9608425W WO 9640175 A1 WO9640175 A1 WO 9640175A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cells
- stromal
- dimensional
- tissue
- framework
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/16—Blood plasma; Blood serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
- A61L27/3629—Intestinal tissue, e.g. small intestinal submucosa
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3637—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the origin of the biological material other than human or animal, e.g. plant extracts, algae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3641—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the site of application in the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3839—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3839—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
- A61L27/3843—Connective tissue
- A61L27/386—Ligaments, tendons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3886—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells comprising two or more cell types
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/60—Materials for use in artificial skin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0062—General methods for three-dimensional culture
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/066—Tenocytes; Tendons, Ligaments
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/067—Hepatocytes
- C12N5/0671—Three-dimensional culture, tissue culture or organ culture; Encapsulated cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0676—Pancreatic cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0676—Pancreatic cells
- C12N5/0677—Three-dimensional culture, tissue culture or organ culture; Encapsulated cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0684—Cells of the urinary tract or kidneys
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/069—Vascular Endothelial cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/069—Vascular Endothelial cells
- C12N5/0691—Vascular smooth muscle cells; 3D culture thereof, e.g. models of blood vessels
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0697—Artificial constructs associating cells of different lineages, e.g. tissue equivalents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0697—Artificial constructs associating cells of different lineages, e.g. tissue equivalents
- C12N5/0698—Skin equivalents
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5082—Supracellular entities, e.g. tissue, organisms
- G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B10/00—Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements
- A61B10/02—Instruments for taking cell samples or for biopsy
- A61B10/0233—Pointed or sharp biopsy instruments
- A61B10/025—Pointed or sharp biopsy instruments for taking bone, bone marrow or cartilage samples
- A61B2010/0258—Marrow samples
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/0063—Implantable repair or support meshes, e.g. hernia meshes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/08—Muscles; Tendons; Ligaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/34—Sugars
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/11—Epidermal growth factor [EGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/33—Insulin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/335—Glucagon; Glucagon-like peptide [GLP]; Exendin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/38—Hormones with nuclear receptors
- C12N2501/39—Steroid hormones
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/09—Coculture with; Conditioned medium produced by epidermal cells, skin cells, oral mucosa cells
- C12N2502/094—Coculture with; Conditioned medium produced by epidermal cells, skin cells, oral mucosa cells keratinocytes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
- C12N2502/1323—Adult fibroblasts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/28—Vascular endothelial cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2503/00—Use of cells in diagnostics
- C12N2503/04—Screening or testing on artificial tissues
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/30—Synthetic polymers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/30—Synthetic polymers
- C12N2533/40—Polyhydroxyacids, e.g. polymers of glycolic or lactic acid (PGA, PLA, PLGA); Bioresorbable polymers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/70—Polysaccharides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
Abstract
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU60315/96A AU706426B2 (en) | 1995-06-07 | 1996-06-03 | Stromal cell-based three-dimensional culture system for forming tubes, tendons, ligaments and corrective structures |
JP9501032A JPH11506611A (en) | 1995-06-07 | 1996-06-03 | Stromal cell-based three-dimensional culture system for ducts, tendons, ligaments and orthotic structures |
NZ310004A NZ310004A (en) | 1995-06-07 | 1996-06-03 | Stromal cell-based three-dimensional culture system for forming tubes, tendons, ligaments and corrective structures |
EP96917936A EP0831861A4 (en) | 1995-06-07 | 1996-06-03 | Stromal cell-based three-dimensional culture system for forming tubes, tendons, ligaments and corrective structures |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/487,749 US5863531A (en) | 1986-04-18 | 1995-06-07 | In vitro preparation of tubular tissue structures by stromal cell culture on a three-dimensional framework |
US487,749 | 1995-06-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1996040175A1 true WO1996040175A1 (en) | 1996-12-19 |
Family
ID=23936969
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1996/008425 WO1996040175A1 (en) | 1995-06-07 | 1996-06-03 | Stromal cell-based three-dimensional culture system for forming tubes, tendons, ligaments and corrective structures |
Country Status (8)
Country | Link |
---|---|
US (3) | US5863531A (en) |
EP (1) | EP0831861A4 (en) |
JP (1) | JPH11506611A (en) |
KR (1) | KR19990022304A (en) |
AU (1) | AU706426B2 (en) |
CA (1) | CA2224071A1 (en) |
NZ (1) | NZ310004A (en) |
WO (1) | WO1996040175A1 (en) |
Cited By (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999017116A1 (en) * | 1997-10-01 | 1999-04-08 | Biocure Limited | A multicellular in vitro assay of angiogenesis |
WO1999022781A2 (en) * | 1997-10-31 | 1999-05-14 | Children's Medical Center Corporation | Bladder reconstruction |
WO1999062562A1 (en) * | 1998-06-02 | 1999-12-09 | University Of Washington | Prosthetic implant and methods of use for therapeutic gene expression |
WO2000006204A2 (en) * | 1998-07-28 | 2000-02-10 | Advanced Tissue Sciences, Inc. | Genetically engineered cells and tissues |
WO2000032254A1 (en) * | 1998-12-01 | 2000-06-08 | Purdue Research Foundation | Method for vocal cord reconstruction |
EP1088096A1 (en) * | 1998-02-18 | 2001-04-04 | Cell Based Delivery | Methods of screening compounds for bioactivity in organized tissue |
US6225118B1 (en) | 1997-10-01 | 2001-05-01 | Biocure Limited | Multicellular in vitro assay of angiogenesis |
WO2001049827A1 (en) * | 1999-12-29 | 2001-07-12 | Children's Medical Center Corporation | Methods and compositions for reconstruction of multilayered tissue structures |
JP2002544235A (en) * | 1999-05-14 | 2002-12-24 | アドバンスド ティシュー サイエンシズ,インコーポレーテッド | Cell culture conditioned medium composition and method of use |
JP2002543916A (en) * | 1999-05-14 | 2002-12-24 | グレゴリー アルトマン, | Bioengineered anterior cruciate ligament |
JP2003500113A (en) * | 1999-05-26 | 2003-01-07 | ザ ブリガム アンド ウイミンズ ホスピタル、 インコーポレイテッド | Therapeutic use of drugs that modulate alpha smooth muscle actin activity |
US6537806B1 (en) | 1998-06-02 | 2003-03-25 | University Of Washington | Compositions and methods for treating diabetes |
WO2003034945A1 (en) * | 2001-10-24 | 2003-05-01 | Katsuko Sakai | Artificial vessel and process for producing the same |
WO2003039614A1 (en) * | 2001-11-06 | 2003-05-15 | Shin-Ichi Kanemaru | Base material for regenerating air sinus and regeneration method |
US6710025B1 (en) | 1999-05-26 | 2004-03-23 | The Brigham And Women's Hospital, Inc. | Treatment of damaged tissue using agents that modulate the activity of alpha-smooth muscle actin |
US6918396B1 (en) | 1998-12-01 | 2005-07-19 | Purdue Research Foundation | Method for vocal cord reconstruction |
DE102004024635A1 (en) * | 2004-05-12 | 2005-12-08 | Deutsche Gelatine-Fabriken Stoess Ag | Process for the preparation of moldings based on crosslinked gelatin |
US8318484B2 (en) | 2008-11-12 | 2012-11-27 | Tengion, Inc. | Isolated renal cells and uses thereof |
US8372433B2 (en) | 2007-01-18 | 2013-02-12 | Gunze Limited | Substrate for culture of cardiovascular tissue |
US8748142B2 (en) | 1999-09-09 | 2014-06-10 | Gunze Limited | Culture of cardiovascular cells on a matrix and method for regenerating cardiovascular tissue |
US8945218B2 (en) | 2000-03-24 | 2015-02-03 | Drexel University | Ligament and tendon replacement constructs and methods for production and use thereof |
US9534203B2 (en) | 2007-06-08 | 2017-01-03 | Wake Forest University Health Sciences | Selective cell therapy for the treatment of renal failure |
US9580688B2 (en) | 2007-06-08 | 2017-02-28 | Wake Forest University Health Sciences | Kidney structures and methods of forming the same |
US9724367B2 (en) | 2010-11-10 | 2017-08-08 | Regenmed (Cayman) Ltd. | Injectable formulations for organ augmentation |
US10077442B2 (en) | 2010-05-12 | 2018-09-18 | Inregen | Bioactive renal cells |
US10590391B2 (en) | 2007-06-08 | 2020-03-17 | Wake Forest University Health Sciences | Selective cell therapy for the treatment of renal failure |
US11123372B2 (en) | 2016-07-29 | 2021-09-21 | Prokidney | Bioactive renal cells for the treatment of chronic kidney disease |
Families Citing this family (287)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5863531A (en) * | 1986-04-18 | 1999-01-26 | Advanced Tissue Sciences, Inc. | In vitro preparation of tubular tissue structures by stromal cell culture on a three-dimensional framework |
US6967086B2 (en) * | 1991-04-18 | 2005-11-22 | Becton Dickinson And Company | Method for determining the presence or absence of respiring cells on a three-dimensional scaffold |
GB9306449D0 (en) | 1993-03-29 | 1993-05-19 | Nat Heart Research Fund | Tissue equivalents |
US6703017B1 (en) | 1994-04-28 | 2004-03-09 | Ixion Biotechnology, Inc. | Reversal of insulin-dependent diabetes by islet-producing stem cells, islet progenitor cells and islet-like structures |
US6485723B1 (en) * | 1995-02-10 | 2002-11-26 | Purdue Research Foundation | Enhanced submucosal tissue graft constructs |
US7608262B2 (en) * | 1996-02-16 | 2009-10-27 | The Kennedy Institute Of Rheumatology | Methods of preventing or treating thrombosis with tumor necrosis factor antagonists |
WO1998036704A1 (en) * | 1997-02-20 | 1998-08-27 | Keller Gregory S | Augmentation and repair of dermal, subcutaneous, and vocal cord tissue defects |
US7767452B2 (en) * | 1997-02-20 | 2010-08-03 | Kleinsek Don A | Tissue treatments with adipocyte cells |
EP1019492A1 (en) | 1997-07-03 | 2000-07-19 | Massachusetts Institute Of Technology | Tissue-engineered constructs |
DE19755023C2 (en) * | 1997-12-11 | 2000-03-09 | Celanese Chem Europe Gmbh | Catalyst and process for making vinyl acetate |
US20100030340A1 (en) * | 1998-06-30 | 2010-02-04 | Wolfinbarger Jr Lloyd | Plasticized Grafts and Methods of Making and Using Same |
US7063726B2 (en) * | 1998-06-30 | 2006-06-20 | Lifenet | Plasticized bone grafts and methods of making and using same |
US6293970B1 (en) | 1998-06-30 | 2001-09-25 | Lifenet | Plasticized bone and soft tissue grafts and methods of making and using same |
US6743574B1 (en) | 2000-09-12 | 2004-06-01 | Lifenet | Process for devitalizing soft-tissue engineered medical implants, and devitalized soft-tissue medical implants produced |
US6734018B2 (en) * | 1999-06-07 | 2004-05-11 | Lifenet | Process for decellularizing soft-tissue engineered medical implants, and decellularized soft-tissue medical implants produced |
US8563232B2 (en) * | 2000-09-12 | 2013-10-22 | Lifenet Health | Process for devitalizing soft-tissue engineered medical implants, and devitalized soft-tissue medical implants produced |
IL144187A0 (en) | 1999-01-14 | 2002-05-23 | Advanced Tissue Sciences Inc | Apparatus and method for sterilizing, seeding, culturing, storing, shipping and testing tissue, synthetic, or native vascular grafts |
US7001746B1 (en) | 1999-01-29 | 2006-02-21 | Artecel Sciences, Inc. | Methods and compositions for the differentiation of human preadipocytes into adipocytes |
US20030007954A1 (en) * | 1999-04-12 | 2003-01-09 | Gail K. Naughton | Methods for using a three-dimensional stromal tissue to promote angiogenesis |
GB9910377D0 (en) * | 1999-05-05 | 1999-06-30 | Univ Westminster | Tissue engineering |
US20040167634A1 (en) * | 1999-05-26 | 2004-08-26 | Anthony Atala | Prosthetic kidney and its use for treating kidney disease |
US20020095157A1 (en) | 1999-07-23 | 2002-07-18 | Bowman Steven M. | Graft fixation device combination |
US6179840B1 (en) | 1999-07-23 | 2001-01-30 | Ethicon, Inc. | Graft fixation device and method |
US7078232B2 (en) | 1999-08-19 | 2006-07-18 | Artecel, Inc. | Adipose tissue-derived adult stem or stromal cells for the repair of articular cartilage fractures and uses thereof |
US6555374B1 (en) | 1999-08-19 | 2003-04-29 | Artecel Sciences, Inc. | Multiple mesodermal lineage differentiation potentials for adipose tissue-derived stromal cells and uses thereof |
US6429013B1 (en) | 1999-08-19 | 2002-08-06 | Artecel Science, Inc. | Use of adipose tissue-derived stromal cells for chondrocyte differentiation and cartilage repair |
KR20020059382A (en) * | 1999-08-31 | 2002-07-12 | 버지니아 주립대학교 지적재산재단 | Engineered muscle |
CA2385628A1 (en) * | 1999-09-27 | 2001-04-05 | Ammon B. Peck | Reversal of insulin-dependent diabetes by islet-producing stem cells, islet progenitor cells and islet-like structures |
US6440164B1 (en) * | 1999-10-21 | 2002-08-27 | Scimed Life Systems, Inc. | Implantable prosthetic valve |
US20080267923A2 (en) * | 1999-11-05 | 2008-10-30 | Donald Kleinsek | Hair undifferentiated cells |
US7799325B2 (en) * | 1999-11-05 | 2010-09-21 | Kleinsek Donald A | Removal of hypertrophic scars |
AU1472501A (en) * | 1999-11-05 | 2001-05-14 | Gerigene Medical Corporation | Augmentation and repair of age-related soft tissue defects |
US20080286242A2 (en) * | 1999-11-05 | 2008-11-20 | Donald Kleinsek | Augmentation and repair of spincter defects with cells including mesenchymal cells |
US20090074729A2 (en) * | 1999-11-05 | 2009-03-19 | Donald Kleinsek | Augmentation and repair of spincter defects with cells including fibroblasts |
US6503273B1 (en) * | 1999-11-22 | 2003-01-07 | Cyograft Tissue Engineering, Inc. | Tissue engineered blood vessels and methods and apparatus for their manufacture |
US6432712B1 (en) * | 1999-11-22 | 2002-08-13 | Bioscience Consultants, Llc | Transplantable recellularized and reendothelialized vascular tissue graft |
US6479064B1 (en) * | 1999-12-29 | 2002-11-12 | Children's Medical Center Corporation | Culturing different cell populations on a decellularized natural biostructure for organ reconstruction |
US6368859B1 (en) | 1999-12-29 | 2002-04-09 | Children's Medical Center Corporation | Methods and compositions for producing a fascial sling |
US6376244B1 (en) | 1999-12-29 | 2002-04-23 | Children's Medical Center Corporation | Methods and compositions for organ decellularization |
PT1261694E (en) | 2000-02-26 | 2008-04-03 | Artecel Inc | Pleuripotent stem cells generated from adipose tissue-derived stromal cells and uses thereof |
US7582292B2 (en) | 2000-02-26 | 2009-09-01 | Artecel, Inc. | Adipose tissue derived stromal cells for the treatment of neurological disorders |
EP1918366A1 (en) | 2000-02-26 | 2008-05-07 | Artecel, Inc. | Pleuripotent stem cells generated from adipose tissue-derived stromal cells and uses thereof |
AU2001251599B2 (en) * | 2000-04-14 | 2006-03-02 | University Of Pittsburgh | Soft tissue and bone augmentation and bulking utilizing muscle-derived progenitor cells, compositions and treatments thereof |
CA2407612C (en) * | 2000-04-28 | 2010-07-06 | Children's Medical Center Corporation | Tissue engineered stents |
DE10026482A1 (en) * | 2000-05-29 | 2001-12-13 | Augustinus Bader | Process for the production of a bioartificial graft |
AU6904101A (en) * | 2000-05-31 | 2001-12-11 | Fraunhofer-Gesellschaft Zur Forderung Der Angewandten Forschung E.V. | Infection model |
US7635592B2 (en) * | 2000-08-21 | 2009-12-22 | Rice University | Tissue engineering scaffolds promoting matrix protein production |
US20020146817A1 (en) * | 2000-10-02 | 2002-10-10 | Cannon Thomas F. | Automated bioculture and bioculture experiments system |
AU2002230941A1 (en) * | 2000-10-31 | 2002-05-15 | Prodesco, Inc. | Supported lattice for cell cultivation |
US20090130066A1 (en) * | 2000-11-06 | 2009-05-21 | Gerigene Medical Corporation | Augmentation and repair of sphincter defects with cells including muscle cells |
US6835390B1 (en) * | 2000-11-17 | 2004-12-28 | Jon Vein | Method for producing tissue engineered meat for consumption |
US7311905B2 (en) * | 2002-02-13 | 2007-12-25 | Anthrogenesis Corporation | Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells |
US20080152629A1 (en) * | 2000-12-06 | 2008-06-26 | James Edinger | Placental stem cell populations |
CA2430989A1 (en) | 2000-12-06 | 2002-06-13 | Robert J. Hariri | Method of collecting placental stem cells |
US6852330B2 (en) * | 2000-12-21 | 2005-02-08 | Depuy Mitek, Inc. | Reinforced foam implants with enhanced integrity for soft tissue repair and regeneration |
US6599323B2 (en) * | 2000-12-21 | 2003-07-29 | Ethicon, Inc. | Reinforced tissue implants and methods of manufacture and use |
CA2365376C (en) * | 2000-12-21 | 2006-03-28 | Ethicon, Inc. | Use of reinforced foam implants with enhanced integrity for soft tissue repair and regeneration |
KR100648405B1 (en) * | 2001-02-07 | 2006-11-24 | 한국원자력연구소 | Method for isolating primary epithelial cells and reconstructing skin equivalents or dermis equivalents with primary culture cells |
WO2002063962A1 (en) * | 2001-02-14 | 2002-08-22 | Hariri Robert J | Renovation and repopulation of decellularized tissues and cadaveric organs by stem cells |
EP2316919B1 (en) | 2001-02-14 | 2015-10-07 | Anthrogenesis Corporation | Post-partum mammalian placenta, its use and placental stem cells therefrom |
US7326564B2 (en) | 2001-02-20 | 2008-02-05 | St. Jude Medical, Inc. | Flow system for medical device evaluation and production |
CA2438904C (en) * | 2001-02-23 | 2012-09-04 | The University Of Pittsburgh | Rapid preparation of stem cell matrices for use in tissue and organ treatment and repair |
US7029838B2 (en) | 2001-03-30 | 2006-04-18 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Prevascularized contructs for implantation to provide blood perfusion |
US7029689B2 (en) * | 2001-05-10 | 2006-04-18 | Georgia Tech Research Corporation | Tubular construct for implantation |
EP1444994B1 (en) | 2001-10-15 | 2014-07-30 | Japan Science and Technology Agency | Method of forming normal regenerated tissue, the normal regenerated tissue, and method of calibrating senstivity and so on |
US20030166274A1 (en) * | 2001-11-15 | 2003-09-04 | Hewitt Charles W. | Three-dimensional matrix for producing living tissue equivalents |
JP2005509495A (en) * | 2001-11-16 | 2005-04-14 | チルドレンズ メディカル センター コーポレーション | Enhancement of organ function |
AU2002343749B2 (en) * | 2001-11-16 | 2007-07-12 | Children's Medical Center Corporation | Creation of tissue engineered female reproductive organs |
TWI222997B (en) * | 2001-12-10 | 2004-11-01 | Ind Tech Res Inst | Method for tissue culture in vitro |
US7504258B2 (en) * | 2001-12-11 | 2009-03-17 | Cytograft Tissue Engineering, Inc. | Tissue engineered cellular sheets, methods of making and use thereof |
DE10203644A1 (en) * | 2002-01-30 | 2003-08-07 | Fraunhofer Ges Forschung | Cryopreservation on textile fabrics |
WO2003072128A2 (en) * | 2002-02-22 | 2003-09-04 | Ebi, L.P. | Methods and compositions for treating bone or cartilage defects |
KR100496354B1 (en) * | 2002-03-27 | 2005-06-20 | 서울산업대학교 산학협력단 | Hybrid Grafts Including Biodegradable Polymer Supporting Layer And Manufacturing Process Thereof |
AU2003230792A1 (en) * | 2002-04-03 | 2003-10-20 | Artecel Sciences, Inc. | Improvements of adipocytic differentiated adipose derived adult stem cells and uses thereof |
JP2005524426A (en) * | 2002-05-02 | 2005-08-18 | パーデュー・リサーチ・ファウンデーション | Graft composition with enhanced angiogenesis |
WO2003092471A2 (en) * | 2002-05-02 | 2003-11-13 | Cook Biotech Incorporated | Cell-seeded extracellular matrix grafts |
JP2005524699A (en) | 2002-05-02 | 2005-08-18 | パーデュー・リサーチ・ファウンデーション | Graft composition with enhanced angiogenesis |
JP2005533535A (en) * | 2002-05-02 | 2005-11-10 | パーデュー・リサーチ・ファウンデーション | Graft composition with enhanced angiogenesis |
US20030229394A1 (en) * | 2002-06-06 | 2003-12-11 | Ogle Matthew F. | Processed tissue for medical device formation |
US6943021B2 (en) * | 2002-06-07 | 2005-09-13 | Mattek Corporation | Three dimensional vaginal tissue model containing immune cells |
US7229820B2 (en) * | 2002-06-13 | 2007-06-12 | Wilson Wolf Manufacturing Corporation | Apparatus and method for culturing and preserving tissue constructs |
AU2003275140A1 (en) * | 2002-09-23 | 2004-04-08 | Massachusetts Institute Of Technology | Theree-dimensional construct for the design and fabrication of physiological fluidic networks |
US20040062753A1 (en) * | 2002-09-27 | 2004-04-01 | Alireza Rezania | Composite scaffolds seeded with mammalian cells |
AU2003275326A1 (en) * | 2002-09-30 | 2004-04-23 | Massachussetts Eye And Ear Infirmary | In vitro culture of tissue structures |
US20040078090A1 (en) | 2002-10-18 | 2004-04-22 | Francois Binette | Biocompatible scaffolds with tissue fragments |
US7824701B2 (en) | 2002-10-18 | 2010-11-02 | Ethicon, Inc. | Biocompatible scaffold for ligament or tendon repair |
US6998264B2 (en) * | 2002-11-19 | 2006-02-14 | Huntington Medical Research Institutes | Replication of biological tissue |
KR101042448B1 (en) | 2002-11-26 | 2011-06-16 | 안트로제네시스 코포레이션 | Cytotherapeutics, cytotherapeutic units and methods for treatments using them |
US20050059153A1 (en) * | 2003-01-22 | 2005-03-17 | George Frank R. | Electromagnetic activation of gene expression and cell growth |
US8940292B2 (en) | 2003-01-28 | 2015-01-27 | Wake Forest University Health Sciences | Enhancement of angiogenesis to grafts using cells engineered to produce growth factors |
US20040156878A1 (en) * | 2003-02-11 | 2004-08-12 | Alireza Rezania | Implantable medical device seeded with mammalian cells and methods of treatment |
MXPA05008445A (en) * | 2003-02-13 | 2005-10-18 | Anthrogenesis Corp | Use of umbilical cord blood to treat individuals having a disease, disorder or condition. |
WO2004076608A2 (en) * | 2003-02-26 | 2004-09-10 | Georgia Tech Research Corporation | Bioreactor and methods for tissue growth and conditioning |
US8197837B2 (en) | 2003-03-07 | 2012-06-12 | Depuy Mitek, Inc. | Method of preparation of bioabsorbable porous reinforced tissue implants and implants thereof |
US20040176855A1 (en) * | 2003-03-07 | 2004-09-09 | Acell, Inc. | Decellularized liver for repair of tissue and treatment of organ deficiency |
CN1812800B (en) * | 2003-04-25 | 2013-01-16 | 匹兹堡大学 | Muscle derived cells(mdc) for promoting and enhancing nerve repair and regeneration |
US20050123520A1 (en) * | 2003-05-05 | 2005-06-09 | Eavey Roland D. | Generation of living tissue in vivo using a mold |
US7960166B2 (en) | 2003-05-21 | 2011-06-14 | The General Hospital Corporation | Microfabricated compositions and processes for engineering tissues containing multiple cell types |
US8790637B2 (en) | 2003-06-27 | 2014-07-29 | DePuy Synthes Products, LLC | Repair and regeneration of ocular tissue using postpartum-derived cells |
US20060223177A1 (en) | 2003-06-27 | 2006-10-05 | Ethicon Inc. | Postpartum cells derived from umbilical cord tissue, and methods of making and using the same |
US8518390B2 (en) | 2003-06-27 | 2013-08-27 | Advanced Technologies And Regenerative Medicine, Llc | Treatment of stroke and other acute neural degenerative disorders via intranasal administration of umbilical cord-derived cells |
US9572840B2 (en) | 2003-06-27 | 2017-02-21 | DePuy Synthes Products, Inc. | Regeneration and repair of neural tissue using postpartum-derived cells |
CA2530533C (en) | 2003-06-27 | 2015-02-10 | Ethicon, Incorporated | Postpartum cells derived from umbilical cord tissue, and methods of making and using the same |
US9592258B2 (en) | 2003-06-27 | 2017-03-14 | DePuy Synthes Products, Inc. | Treatment of neurological injury by administration of human umbilical cord tissue-derived cells |
US7875273B2 (en) | 2004-12-23 | 2011-01-25 | Ethicon, Incorporated | Treatment of Parkinson's disease and related disorders using postpartum derived cells |
US7875272B2 (en) | 2003-06-27 | 2011-01-25 | Ethicon, Incorporated | Treatment of stroke and other acute neuraldegenerative disorders using postpartum derived cells |
US8491883B2 (en) | 2003-06-27 | 2013-07-23 | Advanced Technologies And Regenerative Medicine, Llc | Treatment of amyotrophic lateral sclerosis using umbilical derived cells |
US8226715B2 (en) | 2003-06-30 | 2012-07-24 | Depuy Mitek, Inc. | Scaffold for connective tissue repair |
US10583220B2 (en) | 2003-08-11 | 2020-03-10 | DePuy Synthes Products, Inc. | Method and apparatus for resurfacing an articular surface |
GB0321337D0 (en) * | 2003-09-11 | 2003-10-15 | Massone Mobile Advertising Sys | Method and system for distributing advertisements |
US7316822B2 (en) | 2003-11-26 | 2008-01-08 | Ethicon, Inc. | Conformable tissue repair implant capable of injection delivery |
EP1694328A4 (en) * | 2003-12-02 | 2010-02-17 | Celgene Corp | Methods and compositions for the treatment and management of hemoglobinopathy and anemia |
US7901461B2 (en) | 2003-12-05 | 2011-03-08 | Ethicon, Inc. | Viable tissue repair implants and methods of use |
CA2550326A1 (en) * | 2003-12-19 | 2005-07-14 | Viacell, Inc. | Use of human cord blood-derived pluripotent cells for the treatment of disease |
US7114074B2 (en) * | 2003-12-22 | 2006-09-26 | Graphic Security Systems Corporation | Method and system for controlling encoded image production using image signatures |
WO2005069987A2 (en) * | 2004-01-23 | 2005-08-04 | City Of Hope | Amplifying interfering rna (rnai) expression and effects |
US11395865B2 (en) | 2004-02-09 | 2022-07-26 | DePuy Synthes Products, Inc. | Scaffolds with viable tissue |
EP1713903A2 (en) * | 2004-02-09 | 2006-10-25 | Indiana University Research and Technology Corporation | Isolation, expansion and use of clonogenic endothelial progenitor cells |
AU2005221095A1 (en) * | 2004-03-09 | 2005-09-22 | John J. O'neil | Methods for generating insulin-producing cells |
US8137686B2 (en) | 2004-04-20 | 2012-03-20 | Depuy Mitek, Inc. | Nonwoven tissue scaffold |
US8657881B2 (en) * | 2004-04-20 | 2014-02-25 | Depuy Mitek, Llc | Meniscal repair scaffold |
US8221780B2 (en) | 2004-04-20 | 2012-07-17 | Depuy Mitek, Inc. | Nonwoven tissue scaffold |
WO2005110050A2 (en) * | 2004-05-11 | 2005-11-24 | Synthasome Inc. | Tissue scaffold |
US7393687B2 (en) * | 2004-07-16 | 2008-07-01 | William Marsh Rice University | Biomimetic 3-dimensional scaffold with metabolic stream separation for bioartificial liver device |
US20060115460A1 (en) * | 2004-08-30 | 2006-06-01 | Naughton Gail K | Compositions and methods comprising WNT proteins to promote repair of damaged tissue |
JP2008511672A (en) * | 2004-08-30 | 2008-04-17 | セレゲン,インコーポレーテッド | Cultured three-dimensional tissue and use thereof |
ES2378822T3 (en) * | 2004-09-17 | 2012-04-18 | Jon Vein | Tissue engineering meat for consumption and method for producing tissue engineering meat for consumption |
CN101940801B (en) * | 2004-12-08 | 2014-04-16 | 夏尔再生医学公司 | Methods and compositions for enhancing vascular access |
US8017395B2 (en) | 2004-12-17 | 2011-09-13 | Lifescan, Inc. | Seeding cells on porous supports |
US20060171930A1 (en) * | 2004-12-21 | 2006-08-03 | Agnieszka Seyda | Postpartum cells derived from umbilical cord tissue, and methods of making, culturing, and using the same |
WO2006083394A2 (en) * | 2004-12-21 | 2006-08-10 | Ethicon, Inc. | Postpartum cells derived from placental tissue, and methods of making, culturing, and using the same |
DE602006014814D1 (en) | 2005-04-21 | 2010-07-22 | Massachusetts Inst Technology | MATERIALS AND METHOD FOR CHANGING AN IMMUNE RESPONSE TO EXOGENOUS AND ENDOGENOUS IMMUNOGENES, INCLUDING GENIDENTIAL AND NON-GENIDENTIAL CELLS, TISSUE OR ORGANS |
AU2006202209B2 (en) | 2005-05-27 | 2011-04-14 | Lifescan, Inc. | Amniotic fluid derived cells |
JP2009500297A (en) * | 2005-06-08 | 2009-01-08 | セントカー・インコーポレーテツド | Cell therapy for ocular degeneration |
WO2007001351A1 (en) * | 2005-06-17 | 2007-01-04 | Iken Tissue Therapeutics, Inc. | Methods for treating ischemic tissue |
EP2361591A3 (en) | 2005-06-21 | 2011-12-21 | Pervasis Therapeutics, Inc. | Methods and compositions for enhancing vascular access |
US20070065415A1 (en) * | 2005-09-16 | 2007-03-22 | Kleinsek Donald A | Compositions and methods for the augmentation and repair of defects in tissue |
JP2009508650A (en) * | 2005-09-21 | 2009-03-05 | ダスク テクノロジーズ, エルエルシー | Methods and compositions for organ and tissue function |
NZ597304A (en) * | 2005-10-13 | 2013-06-28 | Anthrogenesis Corp | Immunomodulation using placental stem cells |
US20070122448A1 (en) * | 2005-11-28 | 2007-05-31 | Alireza Rezania | Compositions and methods to create a vascularized environment for cellular transplantation |
US20070128243A1 (en) * | 2005-12-02 | 2007-06-07 | Xylos Corporation | Implantable microbial cellulose materials for various medical applications |
US20100204783A1 (en) * | 2005-12-06 | 2010-08-12 | Helen Marie Nugent | Methods and compositions for enhancing vascular access |
US9175261B2 (en) | 2005-12-16 | 2015-11-03 | DePuy Synthes Products, Inc. | Human umbilical cord tissue cells for inhibiting adverse immune response in histocompatibility-mismatched transplantation |
JP5179376B2 (en) | 2005-12-19 | 2013-04-10 | エシコン・インコーポレイテッド | In vitro growth of postpartum-extracted cells in roller bottles |
US9125906B2 (en) | 2005-12-28 | 2015-09-08 | DePuy Synthes Products, Inc. | Treatment of peripheral vascular disease using umbilical cord tissue-derived cells |
WO2007076522A2 (en) * | 2005-12-28 | 2007-07-05 | Ethicon, Incorporated | Treatment of peripheral vascular disease using postpartum-derived cells |
JP5550235B2 (en) | 2005-12-29 | 2014-07-16 | アントフロゲネシス コーポレーション | Placental stem cell population |
AU2006332679A1 (en) | 2005-12-29 | 2007-07-12 | Anthrogenesis Corporation | Co-culture of placental stem cells and stem cells from a second source |
KR100712724B1 (en) * | 2006-02-14 | 2007-05-04 | 한국원자력연구소 | Method for isolating primary epithelial cells and reconstructing skin equivalents or dermis equivalents with primary culture cells |
SG170761A1 (en) * | 2006-03-23 | 2011-05-30 | Pluristem Ltd | Methods for cell expansion and uses of cells and conditioned media produced thereby for therapy |
EP3527658A1 (en) | 2006-04-28 | 2019-08-21 | Lifescan, Inc. | Differentiation of human embryonic stem cells |
US8741643B2 (en) * | 2006-04-28 | 2014-06-03 | Lifescan, Inc. | Differentiation of pluripotent stem cells to definitive endoderm lineage |
CN104099290A (en) | 2006-10-23 | 2014-10-15 | 人类起源公司 | Methods and compositions for treatment of bone defects with placental cell populations |
JP5372764B2 (en) * | 2006-11-07 | 2013-12-18 | シャイア リジェネラティブ メディシン, インコーポレイテッド | Materials and methods for the treatment and management of angiogenesis-related diseases |
WO2008061261A2 (en) * | 2006-11-17 | 2008-05-22 | Cytograft Tissue Engineering, Inc. | Preparation and use of cell-synthesized threads |
CN101641436A (en) * | 2007-01-30 | 2010-02-03 | 佐治亚大学研究基金会 | Be used to produce the promptly stable mesendoderm cell mass of early stage mesoblastema of entoderm and mesoblastema system and multipotency wandering cell (MMC) |
CN103356711A (en) * | 2007-02-12 | 2013-10-23 | 人类起源公司 | Immunomodulation using placental stem cells |
WO2008101100A2 (en) * | 2007-02-14 | 2008-08-21 | Indiana University Research And Technology Corporation | Composition for stimulating formation of vascular structures |
US20100172830A1 (en) * | 2007-03-29 | 2010-07-08 | Cellx Inc. | Extraembryonic Tissue cells and method of use thereof |
EP3473093B1 (en) | 2007-04-12 | 2020-10-28 | The General Hospital Corporation | Biomimetic vascular network |
EP2155860B1 (en) | 2007-05-03 | 2014-08-27 | The Brigham and Women's Hospital, Inc. | Multipotent stem cells and uses thereof |
TWM322542U (en) * | 2007-05-23 | 2007-11-21 | Universal Scient Ind Co Ltd | Testing machine |
WO2008156705A1 (en) * | 2007-06-13 | 2008-12-24 | Pervasis Therapeutics, Inc. | Methods and devices for minimally-invasive delivery of cell-containing flowable compositions |
US9080145B2 (en) * | 2007-07-01 | 2015-07-14 | Lifescan Corporation | Single pluripotent stem cell culture |
KR20170116172A (en) | 2007-07-01 | 2017-10-18 | 라이프스캔, 인코포레이티드 | Single pluripotent stem cell culture |
US20090024224A1 (en) | 2007-07-16 | 2009-01-22 | Chen Silvia S | Implantation of cartilage |
KR101555824B1 (en) | 2007-07-18 | 2015-09-25 | 라이프스캔, 인코포레이티드 | Differentiation of human embryonic stem cells |
RU2473685C2 (en) | 2007-07-31 | 2013-01-27 | Лайфскен, Инк. | Differentiation of human embryo stem cells |
US9200253B1 (en) | 2007-08-06 | 2015-12-01 | Anthrogenesis Corporation | Method of producing erythrocytes |
KR20160092062A (en) * | 2007-09-26 | 2016-08-03 | 안트로제네시스 코포레이션 | Angiogenic cells from human placental perfusate |
AU2008307633C1 (en) | 2007-09-28 | 2015-04-30 | Celularity Inc. | Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells |
JP5323845B2 (en) | 2007-10-05 | 2013-10-23 | エシコン・インコーポレイテッド | Repair and reconstruction of kidney tissue using human umbilical cord tissue-derived cells |
KR20100100855A (en) * | 2007-11-07 | 2010-09-15 | 안트로제네시스 코포레이션 | Use of umbilical cord blood in the treatment of premature birth complications |
JP5252538B2 (en) * | 2007-11-09 | 2013-07-31 | グンゼ株式会社 | Method for producing cultured blood vessel having elastic fiber tissue and cultured blood vessel having elastic fiber tissue |
RU2473684C2 (en) * | 2007-11-27 | 2013-01-27 | Лайфскен, Инк. | Differentiation of human embryo stem cells |
US8236538B2 (en) | 2007-12-20 | 2012-08-07 | Advanced Technologies And Regenerative Medicine, Llc | Methods for sterilizing materials containing biologically active agents |
US11051733B2 (en) * | 2008-01-18 | 2021-07-06 | Wake Forest University Health Sciences | Isolating and purifying cells for therapy |
WO2009102751A2 (en) | 2008-02-11 | 2009-08-20 | The General Hospital Corporation | System and method for in vitro blood vessel modeling |
US9393002B2 (en) | 2008-02-18 | 2016-07-19 | Covidien Lp | Clip for implant deployment device |
EP2247245B1 (en) | 2008-02-18 | 2017-06-28 | Covidien LP | A device for deploying and attaching a patch to a biological tissue |
US9034002B2 (en) | 2008-02-18 | 2015-05-19 | Covidien Lp | Lock bar spring and clip for implant deployment device |
US9301826B2 (en) | 2008-02-18 | 2016-04-05 | Covidien Lp | Lock bar spring and clip for implant deployment device |
US8317808B2 (en) * | 2008-02-18 | 2012-11-27 | Covidien Lp | Device and method for rolling and inserting a prosthetic patch into a body cavity |
US9398944B2 (en) | 2008-02-18 | 2016-07-26 | Covidien Lp | Lock bar spring and clip for implant deployment device |
US9393093B2 (en) | 2008-02-18 | 2016-07-19 | Covidien Lp | Clip for implant deployment device |
US9833240B2 (en) | 2008-02-18 | 2017-12-05 | Covidien Lp | Lock bar spring and clip for implant deployment device |
US8758373B2 (en) * | 2008-02-18 | 2014-06-24 | Covidien Lp | Means and method for reversibly connecting a patch to a patch deployment device |
US8808314B2 (en) * | 2008-02-18 | 2014-08-19 | Covidien Lp | Device and method for deploying and attaching an implant to a biological tissue |
US9044235B2 (en) | 2008-02-18 | 2015-06-02 | Covidien Lp | Magnetic clip for implant deployment device |
KR102026622B1 (en) * | 2008-02-21 | 2019-09-30 | 얀센 바이오테크 인코포레이티드 | Methods, surface modified plates and compositions for cell attachment, cultivation and detachment |
US8623648B2 (en) | 2008-04-24 | 2014-01-07 | Janssen Biotech, Inc. | Treatment of pluripotent cells |
EP2299934A1 (en) * | 2008-06-16 | 2011-03-30 | Cytograft Tissue Engineering, Inc. | Arterial implants |
WO2010002846A1 (en) | 2008-06-30 | 2010-01-07 | Centocor Ortho Biotech Inc. | Differentiation of pluripotent stem cells |
US8795264B2 (en) * | 2008-07-01 | 2014-08-05 | Ralph Zipper | Method for decreasing the size and/or changing the shape of pelvic tissues |
WO2010011352A2 (en) | 2008-07-25 | 2010-01-28 | The University Of Georgia Research Foundation, Inc. | Compositions for mesoderm derived isl1+ multipotent cells (imps), epicardial progenitor cells (epcs) and multipotent cxcr4+cd56+ cells (c56cs) and methods of use |
US20110305672A1 (en) | 2008-07-25 | 2011-12-15 | University Of Georgia Research Foundation, Inc. | COMPOSITIONS FOR MESODERM DERIVED ISL1+ MULTIPOTENT CELLS (IMPs), EPICARDIAL PROGENITOR CELLS (EPCs) AND MULTIPOTENT CD56C CELLS (C56Cs) AND METHODS OF PRODUCING AND USING SAME |
US20100028307A1 (en) * | 2008-07-31 | 2010-02-04 | O'neil John J | Pluripotent stem cell differentiation |
WO2010017378A2 (en) * | 2008-08-08 | 2010-02-11 | Indiana University Research And Technology Corporation | Methods and compositions for vasculogenic potential determination |
WO2010022083A2 (en) * | 2008-08-18 | 2010-02-25 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Bone augmentation utilizing muscle-derived progenitor compositions in biocompatible matrix, and treatments thereof |
MX2011001992A (en) * | 2008-08-22 | 2011-03-29 | Anthrogenesis Corp | Methods and compositions for treatment of bone defects with placental cell populations. |
CA2730547C (en) * | 2008-10-20 | 2013-08-06 | Polytouch Medical Ltd. | A device for attaching a patch to a biological tissue |
EP2350265B1 (en) | 2008-10-31 | 2019-04-17 | Janssen Biotech, Inc. | Differentiation of human embryonic stem cells to the pancreatic endocrine lineage |
CN102272291B (en) | 2008-10-31 | 2018-01-16 | 詹森生物科技公司 | Differentiation of the human embryo stem cell to pancreatic endocrine pedigree |
CN104274256A (en) * | 2008-11-04 | 2015-01-14 | 坦吉恩股份有限公司 | Cell-scaffold constructs |
GB0820492D0 (en) | 2008-11-07 | 2008-12-17 | Sportcell | Cell compositions and uses thereof |
CN102497871B (en) * | 2008-11-14 | 2014-10-15 | 希斯托金公司 | Extracellular matrix compositions for the treatment of cancer |
RU2562154C2 (en) * | 2008-11-19 | 2015-09-10 | Антродженезис Корпорейшн | Amniotic adhesive cells |
MX356756B (en) | 2008-11-20 | 2018-06-11 | Centocor Ortho Biotech Inc | Pluripotent stem cell culture on micro-carriers. |
EP2366022B1 (en) * | 2008-11-20 | 2016-04-27 | Janssen Biotech, Inc. | Methods and compositions for cell attachment and cultivation on planar substrates |
DK2375907T3 (en) * | 2008-11-21 | 2019-06-11 | Celularity Inc | TREATMENT OF DISEASES, DISORDERS OR CONDITIONS IN THE LUNGERHOUSES USING PLACENTAL CELLS |
EP2379087B1 (en) * | 2008-12-19 | 2014-08-20 | DePuy Synthes Products, LLC | Umbilical cord tissue derived cells for treating neuropathic pain and spasticity |
US10179900B2 (en) | 2008-12-19 | 2019-01-15 | DePuy Synthes Products, Inc. | Conditioned media and methods of making a conditioned media |
JP6095893B2 (en) * | 2008-12-19 | 2017-03-15 | デピュイ・シンセス・プロダクツ・インコーポレイテッド | Regeneration and repair of nerve tissue after injury |
WO2010071864A1 (en) | 2008-12-19 | 2010-06-24 | Ethicon, Incorporated | Treatment of lung and pulmonary diseases and disorders |
WO2010111278A1 (en) | 2009-03-23 | 2010-09-30 | The Texas A&M University System | Compositions of mesenchymal stem cells to regenerate bone |
BRPI1013409A2 (en) | 2009-03-26 | 2018-01-16 | Advanced Tech And Regenerative Medicine Llc | human umbilical cord tissue cells as therapy for alzheimer's disease |
MX340952B (en) | 2009-07-20 | 2016-07-29 | Janssen Biotech Inc | Differentiation of human embryonic stem cells. |
RU2540016C2 (en) | 2009-07-20 | 2015-01-27 | Янссен Байотек, Инк. | Differentiating human embryonic stem cells |
KR102058901B1 (en) | 2009-07-20 | 2019-12-24 | 얀센 바이오테크 인코포레이티드 | Differentiation of human embryonic stem cells |
US8906045B2 (en) * | 2009-08-17 | 2014-12-09 | Covidien Lp | Articulating patch deployment device and method of use |
WO2011021082A1 (en) * | 2009-08-17 | 2011-02-24 | PolyTouch Medical, Inc. | Means and method for reversibly connecting an implant to a deployment device |
AR078805A1 (en) * | 2009-10-29 | 2011-12-07 | Centocor Ortho Biotech Inc | PLURIPOTENT MOTHER CELLS |
US9150833B2 (en) | 2009-12-23 | 2015-10-06 | Janssen Biotech, Inc. | Differentiation of human embryonic stem cells |
KR101841271B1 (en) * | 2009-12-23 | 2018-03-22 | 얀센 바이오테크 인코포레이티드 | Differentiation of human embryonic stem cells |
ES2646750T3 (en) * | 2010-01-26 | 2017-12-15 | Anthrogenesis Corporation | Treatment of bone-related cancers using placental stem cells |
JP6013196B2 (en) * | 2010-03-01 | 2016-10-25 | ヤンセン バイオテツク,インコーポレーテツド | Method for purifying cells derived from pluripotent stem cells |
EP2926821B1 (en) | 2010-03-05 | 2019-12-25 | Tissue Genesis, LLC | Compositions to support tissue integration and inosculation of transplanted tissue and transplanted engineered penile tissue with adipose stromal cells |
KR20190076060A (en) | 2010-04-07 | 2019-07-01 | 안트로제네시스 코포레이션 | Angiogenesis using placental stem cells |
EP2555783A1 (en) | 2010-04-08 | 2013-02-13 | Anthrogenesis Corporation | Treatment of sarcoidosis using placental stem cells |
EP2569419B1 (en) | 2010-05-12 | 2019-03-20 | Janssen Biotech, Inc. | Differentiation of human embryonic stem cells |
US11854427B2 (en) | 2010-06-30 | 2023-12-26 | Strategic Operations, Inc. | Wearable medical trainer |
US11495143B2 (en) | 2010-06-30 | 2022-11-08 | Strategic Operations, Inc. | Emergency casualty care trainer |
US11688303B2 (en) | 2010-06-30 | 2023-06-27 | Strategic Operations, Inc. | Simulated torso for an open surgery simulator |
US10360817B2 (en) * | 2010-06-30 | 2019-07-23 | Stuart Charles Segall | Wearable partial task surgical simulator |
WO2012009422A1 (en) | 2010-07-13 | 2012-01-19 | Anthrogenesis Corporation | Methods of generating natural killer cells |
EP3981415A1 (en) | 2010-08-12 | 2022-04-13 | Janssen Biotech, Inc. | Treatment of diabetes with pancreatic endocrine precursor cells |
SG10201506855RA (en) | 2010-08-31 | 2015-10-29 | Janssen Biotech Inc | Differentiation of human embryonic stem cells |
CA2809305C (en) | 2010-08-31 | 2019-06-11 | Janssen Biotech, Inc. | Differentiation of pluripotent stem cells |
BR112013004514A2 (en) | 2010-08-31 | 2016-06-07 | Janssen Biotech Inc | differentiation of human embryonic stem cells |
US9725689B2 (en) | 2010-10-08 | 2017-08-08 | Terumo Bct, Inc. | Configurable methods and systems of growing and harvesting cells in a hollow fiber bioreactor system |
EP2652125B1 (en) | 2010-12-15 | 2017-04-26 | Kadimastem Ltd. | Insulin producing cells derived from pluripotent stem cells |
WO2012091911A1 (en) | 2010-12-27 | 2012-07-05 | Intellicell Biosciences, Inc. | Ultrasonic cavitation derived stromal or mesenchymal vascular extracts and cells derived therefrom obtained from adipose tissue and use thereof |
US8969315B2 (en) | 2010-12-31 | 2015-03-03 | Anthrogenesis Corporation | Enhancement of placental stem cell potency using modulatory RNA molecules |
US20130295578A1 (en) * | 2011-01-10 | 2013-11-07 | Trustees Of Dartmouth College | Methods for screening for drug resistance in cancer treatment |
US8597948B2 (en) | 2011-03-10 | 2013-12-03 | First Principles, Inc. | Cloned biological material medical device and method thereof |
ES2707579T3 (en) | 2011-06-01 | 2019-04-04 | Celularity Inc | Pain treatment using placental cytoblast |
WO2013055476A1 (en) | 2011-09-09 | 2013-04-18 | Anthrogenesis Corporation | Treatment of amyotrophic lateral sclerosis using placental stem cells |
KR102203056B1 (en) | 2011-12-22 | 2021-01-14 | 얀센 바이오테크 인코포레이티드 | Differentiation of human embryonic stem cells into single hormonal insulin positive cells |
BR112014015424A2 (en) | 2011-12-23 | 2018-05-22 | Depuy Synthes Products Llc | detection of cells derived from human umbilical cord tissue |
WO2013134378A1 (en) | 2012-03-07 | 2013-09-12 | Janssen Biotech, Inc. | Defined media for expansion and maintenance of pluripotent stem cells |
EP2841010B1 (en) | 2012-04-24 | 2023-08-23 | Harvard Apparatus Regenerative Technology, Inc. | Supports for engineered tissue scaffolds |
CN108103006A (en) | 2012-06-08 | 2018-06-01 | 詹森生物科技公司 | Differentiation of the human embryo stem cell to pancreatic endocrine cell |
US9932559B2 (en) * | 2012-11-16 | 2018-04-03 | The Johns Hopkins University | Platform for creating an artificial blood brain barrier |
RU2658488C2 (en) | 2012-12-31 | 2018-06-21 | Янссен Байотек, Инк. | Method for obtaining cells expressing markers characteristic for pancreatic endocrine cells |
EP4039798A1 (en) | 2012-12-31 | 2022-08-10 | Janssen Biotech, Inc. | Suspension and clustering of human pluripotent cells |
US10370644B2 (en) | 2012-12-31 | 2019-08-06 | Janssen Biotech, Inc. | Method for making human pluripotent suspension cultures and cells derived therefrom |
KR101942769B1 (en) | 2012-12-31 | 2019-01-28 | 얀센 바이오테크 인코포레이티드 | Differentiation of human embryonic stem cells into pancreatic endocrine cells using hb9 regulators |
WO2014110300A1 (en) | 2013-01-09 | 2014-07-17 | Harvard Apparatus Regenerative Technology | Synthetic scaffolds |
AU2014215458A1 (en) | 2013-02-05 | 2015-08-13 | Anthrogenesis Corporation | Natural killer cells from placenta |
CN103981147B (en) | 2013-02-08 | 2017-11-10 | 中国科学院上海生命科学研究院 | A kind of new method for preparing hepatic parenchymal cells |
WO2015005349A1 (en) * | 2013-07-09 | 2015-01-15 | 国立大学法人東京大学 | Cell culture support, cell culture device, cell culture kit, and cell sheet |
US9878071B2 (en) | 2013-10-16 | 2018-01-30 | Purdue Research Foundation | Collagen compositions and methods of use |
CN105992816B (en) | 2013-11-16 | 2018-04-17 | 泰尔茂比司特公司 | Cell amplification in bioreactor |
JP6783143B2 (en) | 2014-03-25 | 2020-11-11 | テルモ ビーシーティー、インコーポレーテッド | Passive replenishment of medium |
DK3143127T3 (en) | 2014-05-16 | 2021-09-13 | Janssen Biotech Inc | USE OF SMALL MOLECULES TO ENHANGE MAFA EXPRESSION IN ENDOCRINE PANCREAS CELLS |
US9371516B2 (en) | 2014-09-19 | 2016-06-21 | Regenerative Medical Solutions, Inc. | Compositions and methods for differentiating stem cells into cell populations comprising beta-like cells |
CN106715676A (en) | 2014-09-26 | 2017-05-24 | 泰尔茂比司特公司 | Scheduled feed |
WO2016172365A1 (en) | 2015-04-21 | 2016-10-27 | Purdue Research Foundation Office Of Technology Commercialization | Cell-collagen-silica composites and methods of making and using the same |
WO2017004592A1 (en) | 2015-07-02 | 2017-01-05 | Terumo Bct, Inc. | Cell growth with mechanical stimuli |
US11679133B2 (en) | 2015-11-30 | 2023-06-20 | Kadimastem Ltd. | Methods for differentiating and purifying pancreatic endocrine cells |
US20170281327A1 (en) * | 2016-04-01 | 2017-10-05 | Lee D. Kaplan | Sleeve for soft tissue repair |
MA45479A (en) | 2016-04-14 | 2019-02-20 | Janssen Biotech Inc | DIFFERENTIATION OF PLURIPOTENT STEM CELLS IN ENDODERMAL CELLS OF MIDDLE INTESTINE |
EP3464565A4 (en) | 2016-05-25 | 2020-01-01 | Terumo BCT, Inc. | Cell expansion |
US11104874B2 (en) | 2016-06-07 | 2021-08-31 | Terumo Bct, Inc. | Coating a bioreactor |
US11685883B2 (en) | 2016-06-07 | 2023-06-27 | Terumo Bct, Inc. | Methods and systems for coating a cell growth surface |
CN109689853B (en) | 2016-08-27 | 2022-08-23 | 三维生物科技有限公司 | Bioreactor |
EP3954757A1 (en) * | 2016-12-02 | 2022-02-16 | Emulate, Inc. | In vitro gastrointestinal model comprising lamina propria-derived cells |
US10828638B2 (en) | 2016-12-02 | 2020-11-10 | EMULATE, Inc. | In vitro epithelial models comprising lamina propria-derived cells |
US11624046B2 (en) | 2017-03-31 | 2023-04-11 | Terumo Bct, Inc. | Cell expansion |
JP7393945B2 (en) | 2017-03-31 | 2023-12-07 | テルモ ビーシーティー、インコーポレーテッド | cell proliferation |
WO2018200750A1 (en) | 2017-04-25 | 2018-11-01 | Purdue Research Foundation | 3-dimensional (3d) tissue-engineered muscle for tissue restoration |
WO2018232323A1 (en) | 2017-06-16 | 2018-12-20 | Avery Therapeutics, Inc. | Three dimensional tissue compositions and methods of use |
US11788062B2 (en) | 2017-07-27 | 2023-10-17 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Functional feline pancreatic cells from adipose tissue |
JP2019180354A (en) * | 2018-04-16 | 2019-10-24 | 国立研究開発法人理化学研究所 | Method for producing cell sheet and cell sheet |
US20200157493A1 (en) * | 2018-11-21 | 2020-05-21 | The Secant Group, Llc | Textile growth matrix for cells |
WO2022204377A1 (en) | 2021-03-24 | 2022-09-29 | Salk Institute For Biological Studies | NOVEL CHEMICAL COMBINATIONS AND METHODS OF USE THEREOF, TOWARDS DIFFERENTIATION OF HUMAN PROGENITOR CELLS INTO FUNCTIONAL β CELLS |
CN114958713B (en) * | 2022-05-31 | 2024-02-20 | 杭州赫贝科技有限公司 | Three-dimensional cell culture support of tubular structure |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4505266A (en) * | 1981-10-26 | 1985-03-19 | Massachusetts Institute Of Technology | Method of using a fibrous lattice |
US5041138A (en) * | 1986-11-20 | 1991-08-20 | Massachusetts Institute Of Technology | Neomorphogenesis of cartilage in vivo from cell culture |
US5266480A (en) * | 1986-04-18 | 1993-11-30 | Advanced Tissue Sciences, Inc. | Three-dimensional skin culture system |
US5399665A (en) * | 1992-11-05 | 1995-03-21 | Massachusetts Institute Of Technology | Biodegradable polymers for cell transplantation |
Family Cites Families (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH593339A5 (en) * | 1973-07-02 | 1977-11-30 | Monsanto Co | |
US4144126A (en) * | 1975-05-21 | 1979-03-13 | Beecham Group Limited | Cell culture method |
US4280954A (en) * | 1975-07-15 | 1981-07-28 | Massachusetts Institute Of Technology | Crosslinked collagen-mucopolysaccharide composite materials |
US4016036A (en) * | 1975-11-14 | 1977-04-05 | Massachusetts Institute Of Technology | Process for serially culturing keratinocytes |
US4024020A (en) * | 1975-12-15 | 1977-05-17 | Monsanto Company | Method of cell culture on polyacrylonitrile surface |
DE2557870A1 (en) * | 1975-12-22 | 1977-06-23 | Linde Ag | METHOD AND DEVICE FOR FREEZING BIOLOGICAL SUBSTANCES |
US4087327A (en) * | 1976-04-12 | 1978-05-02 | Monsanto Company | Mammalion cell culture process |
US4117881A (en) * | 1977-06-14 | 1978-10-03 | The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration | System for and method of freezing biological tissue |
US4135975A (en) * | 1977-12-14 | 1979-01-23 | Lichtman Marshall A | Obtaining human cell lines that elaborate colony stimulating activity for marrow cells of man and other species and methods of preparing same |
US4228243A (en) * | 1978-07-13 | 1980-10-14 | Toray Industries, Inc. | Cell culture propagation apparatus |
US4299819A (en) * | 1979-01-02 | 1981-11-10 | Sloan-Kettering Institute For Cancer Research | Process for treating burn victims |
US4342828A (en) * | 1979-07-20 | 1982-08-03 | Morinaga Milk Industry Co., Ltd. | Method for producing substance capable of stimulating differentiation and proliferation of human granulopoietic stem cells |
US4642292A (en) * | 1979-10-29 | 1987-02-10 | Albert Einstein College Of Medicine Of Yeshiva University, A Division Of Yeshiva University | Method for isolation of connective tissue biomatrix |
US4486188A (en) * | 1980-08-14 | 1984-12-04 | Applied Medical Devices, Inc. | Bone marrow transplant method and apparatus |
US4481946A (en) * | 1980-08-14 | 1984-11-13 | Altshuler John H | Bone marrow transplant method and apparatus |
US4553272A (en) * | 1981-02-26 | 1985-11-19 | University Of Pittsburgh | Regeneration of living tissues by growth of isolated cells in porous implant and product thereof |
US4539716A (en) * | 1981-03-19 | 1985-09-10 | Massachusetts Institute Of Technology | Fabrication of living blood vessels and glandular tissues |
US4546500A (en) * | 1981-05-08 | 1985-10-15 | Massachusetts Institute Of Technology | Fabrication of living blood vessels and glandular tissues |
US4489710A (en) * | 1981-06-23 | 1984-12-25 | Xoma Corporation | Composition and method for transplantation therapy |
US4621100A (en) * | 1981-09-25 | 1986-11-04 | The Upjohn Company | Treatment of osteoporosis with prostaglandins |
DE3138597A1 (en) * | 1981-09-29 | 1983-04-14 | Boehringer Mannheim Gmbh, 6800 Mannheim | METHOD FOR GROWING HUMAN FIBROST AND FIBROBLAST-LIKE CELLS |
US4458678A (en) * | 1981-10-26 | 1984-07-10 | Massachusetts Institute Of Technology | Cell-seeding procedures involving fibrous lattices |
JPS5881781A (en) * | 1981-11-11 | 1983-05-17 | Ajinomoto Co Inc | Cultivation method of animal cell |
US4485096A (en) * | 1982-02-26 | 1984-11-27 | Massachusetts Institute Of Technology | Tissue-equivalent and method for preparation thereof |
US4520821A (en) * | 1982-04-30 | 1985-06-04 | The Regents Of The University Of California | Growing of long-term biological tissue correction structures in vivo |
US4485097A (en) * | 1982-05-26 | 1984-11-27 | Massachusetts Institute Of Technology | Bone-equivalent and method for preparation thereof |
US4645669A (en) * | 1982-10-04 | 1987-02-24 | Albert Einstein College Of Medicine Of Yeshiva University | Culturing and emplacement of differentiated cells in vivo |
JPS60123884A (en) * | 1983-12-09 | 1985-07-02 | 三菱電機株式会社 | English learning apparatus |
CA1295796C (en) * | 1984-03-27 | 1992-02-18 | Conrad Whyne | Biodegradable matrix and methods for producing same |
EP0163543A3 (en) * | 1984-06-01 | 1987-08-12 | VXR, Inc. | Marrow cell stimulator |
JPS61227526A (en) * | 1984-07-25 | 1986-10-09 | Chugai Pharmaceut Co Ltd | Novel csf and method of collecting same |
US4604346A (en) * | 1984-10-09 | 1986-08-05 | Massachusetts Institute Of Technology | Skin-equivalent prepared by the use of punch biopsy |
JPS61107643A (en) * | 1984-10-30 | 1986-05-26 | Hitachi Ltd | Ion source with evaporator furnace |
AU589438B2 (en) * | 1985-08-26 | 1989-10-12 | Hana Biologics, Inc. | Transplantable artificial tissue and process |
US4963489A (en) * | 1987-04-14 | 1990-10-16 | Marrow-Tech, Inc. | Three-dimensional cell and tissue culture system |
US4721096A (en) * | 1986-04-18 | 1988-01-26 | Marrow-Tech Incorporated | Process for replicating bone marrow in vitro and using the same |
US5160490A (en) * | 1986-04-18 | 1992-11-03 | Marrow-Tech Incorporated | Three-dimensional cell and tissue culture apparatus |
US5032508A (en) * | 1988-09-08 | 1991-07-16 | Marrow-Tech, Inc. | Three-dimensional cell and tissue culture system |
US5863531A (en) * | 1986-04-18 | 1999-01-26 | Advanced Tissue Sciences, Inc. | In vitro preparation of tubular tissue structures by stromal cell culture on a three-dimensional framework |
US5567612A (en) * | 1986-11-20 | 1996-10-22 | Massachusetts Institute Of Technology | Genitourinary cell-matrix structure for implantation into a human and a method of making |
US5759830A (en) * | 1986-11-20 | 1998-06-02 | Massachusetts Institute Of Technology | Three-dimensional fibrous scaffold containing attached cells for producing vascularized tissue in vivo |
CA1340581C (en) * | 1986-11-20 | 1999-06-08 | Joseph P. Vacanti | Chimeric neomorphogenesis of organs by controlled cellular implantation using artificial matrices |
US4835102A (en) * | 1987-03-31 | 1989-05-30 | Eugene Bell | Tissue equivalent test systems |
US5263984A (en) * | 1987-07-20 | 1993-11-23 | Regen Biologics, Inc. | Prosthetic ligaments |
DE69232899T2 (en) * | 1991-09-16 | 2003-09-11 | Atrium Medical Corp | Implantable multi-lumen, extruded device with controlled porosity and method of manufacture |
IT1263023B (en) * | 1992-11-09 | 1996-07-23 | EPITHELIUM TUBULAR SUPPORT AND METHOD FOR ITS PREPARATION. | |
WO1994025584A1 (en) * | 1993-04-28 | 1994-11-10 | Johns Hopkins University School Of Medicine | Chronic endothelial cell culture under flow |
WO1995033421A1 (en) * | 1994-06-06 | 1995-12-14 | Case Western Reserve University | Biomatrix for tissue regeneration |
-
1995
- 1995-06-07 US US08/487,749 patent/US5863531A/en not_active Expired - Lifetime
-
1996
- 1996-06-03 KR KR1019970708783A patent/KR19990022304A/en not_active Application Discontinuation
- 1996-06-03 EP EP96917936A patent/EP0831861A4/en not_active Ceased
- 1996-06-03 WO PCT/US1996/008425 patent/WO1996040175A1/en not_active Application Discontinuation
- 1996-06-03 CA CA002224071A patent/CA2224071A1/en not_active Abandoned
- 1996-06-03 NZ NZ310004A patent/NZ310004A/en unknown
- 1996-06-03 JP JP9501032A patent/JPH11506611A/en not_active Ceased
- 1996-06-03 AU AU60315/96A patent/AU706426B2/en not_active Ceased
-
1999
- 1999-01-25 US US09/237,980 patent/US6140039A/en not_active Expired - Fee Related
- 1999-03-08 US US09/264,513 patent/US6022743A/en not_active Expired - Fee Related
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4505266A (en) * | 1981-10-26 | 1985-03-19 | Massachusetts Institute Of Technology | Method of using a fibrous lattice |
US5266480A (en) * | 1986-04-18 | 1993-11-30 | Advanced Tissue Sciences, Inc. | Three-dimensional skin culture system |
US5041138A (en) * | 1986-11-20 | 1991-08-20 | Massachusetts Institute Of Technology | Neomorphogenesis of cartilage in vivo from cell culture |
US5399665A (en) * | 1992-11-05 | 1995-03-21 | Massachusetts Institute Of Technology | Biodegradable polymers for cell transplantation |
Non-Patent Citations (1)
Title |
---|
See also references of EP0831861A4 * |
Cited By (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU732538B2 (en) * | 1997-10-01 | 2001-04-26 | Biocure Limited | A multicellular in vitro assay of angiogenesis |
US6475790B2 (en) | 1997-10-01 | 2002-11-05 | Biocure Limited | Assay for screening agents that alter angiogenesis |
WO1999017116A1 (en) * | 1997-10-01 | 1999-04-08 | Biocure Limited | A multicellular in vitro assay of angiogenesis |
US6225118B1 (en) | 1997-10-01 | 2001-05-01 | Biocure Limited | Multicellular in vitro assay of angiogenesis |
WO1999022781A2 (en) * | 1997-10-31 | 1999-05-14 | Children's Medical Center Corporation | Bladder reconstruction |
WO1999022781A3 (en) * | 1997-10-31 | 1999-07-29 | Childrens Medical Center | Bladder reconstruction |
US7569076B2 (en) | 1997-10-31 | 2009-08-04 | Children's Medical Center Corporation | Bladder reconstruction |
US8128707B2 (en) | 1997-10-31 | 2012-03-06 | Children's Medical Center Corporation | Bladder reconstruction |
EP1088096A4 (en) * | 1998-02-18 | 2002-02-06 | Cell Based Delivery | Methods of screening compounds for bioactivity in organized tissue |
EP1088096A1 (en) * | 1998-02-18 | 2001-04-04 | Cell Based Delivery | Methods of screening compounds for bioactivity in organized tissue |
WO1999062562A1 (en) * | 1998-06-02 | 1999-12-09 | University Of Washington | Prosthetic implant and methods of use for therapeutic gene expression |
US7341869B2 (en) | 1998-06-02 | 2008-03-11 | The University Of Washington | Compositions and methods for treating diabetes |
US6537806B1 (en) | 1998-06-02 | 2003-03-25 | University Of Washington | Compositions and methods for treating diabetes |
WO2000006204A3 (en) * | 1998-07-28 | 2000-05-04 | Advanced Tissue Sciences Inc | Genetically engineered cells and tissues |
WO2000006204A2 (en) * | 1998-07-28 | 2000-02-10 | Advanced Tissue Sciences, Inc. | Genetically engineered cells and tissues |
WO2000032254A1 (en) * | 1998-12-01 | 2000-06-08 | Purdue Research Foundation | Method for vocal cord reconstruction |
GB2360948A (en) * | 1998-12-01 | 2001-10-10 | Purdue Research Foundation | Method for vocal cord reconstruction |
GB2360948B (en) * | 1998-12-01 | 2003-12-10 | Purdue Research Foundation | Composition suitable for vocal cord reconstruction |
US6918396B1 (en) | 1998-12-01 | 2005-07-19 | Purdue Research Foundation | Method for vocal cord reconstruction |
US8476231B2 (en) | 1999-05-14 | 2013-07-02 | Allergan, Inc. | Conditioned cell culture medium compositions and methods of use |
US9458486B2 (en) | 1999-05-14 | 2016-10-04 | Allergen, Inc. | Conditioned cell culture medium compositions and methods of use |
US8361485B2 (en) | 1999-05-14 | 2013-01-29 | Skinmedica, Inc. | Conditioned cell culture medium compositions and methods of use |
JP2013010781A (en) * | 1999-05-14 | 2013-01-17 | Skinmedica Inc | Conditioned cell culture medium composition and method of use |
US8138147B2 (en) | 1999-05-14 | 2012-03-20 | Skinmedica, Inc. | Conditioned cell culture medium compositions and methods of use |
JP2002544235A (en) * | 1999-05-14 | 2002-12-24 | アドバンスド ティシュー サイエンシズ,インコーポレーテッド | Cell culture conditioned medium composition and method of use |
JP2002543916A (en) * | 1999-05-14 | 2002-12-24 | グレゴリー アルトマン, | Bioengineered anterior cruciate ligament |
JP2003500113A (en) * | 1999-05-26 | 2003-01-07 | ザ ブリガム アンド ウイミンズ ホスピタル、 インコーポレイテッド | Therapeutic use of drugs that modulate alpha smooth muscle actin activity |
US6710025B1 (en) | 1999-05-26 | 2004-03-23 | The Brigham And Women's Hospital, Inc. | Treatment of damaged tissue using agents that modulate the activity of alpha-smooth muscle actin |
US8748142B2 (en) | 1999-09-09 | 2014-06-10 | Gunze Limited | Culture of cardiovascular cells on a matrix and method for regenerating cardiovascular tissue |
US6428802B1 (en) | 1999-12-29 | 2002-08-06 | Children's Medical Center Corp. | Preparing artificial organs by forming polylayers of different cell populations on a substrate |
WO2001049827A1 (en) * | 1999-12-29 | 2001-07-12 | Children's Medical Center Corporation | Methods and compositions for reconstruction of multilayered tissue structures |
US8945218B2 (en) | 2000-03-24 | 2015-02-03 | Drexel University | Ligament and tendon replacement constructs and methods for production and use thereof |
WO2003034945A1 (en) * | 2001-10-24 | 2003-05-01 | Katsuko Sakai | Artificial vessel and process for producing the same |
WO2003039614A1 (en) * | 2001-11-06 | 2003-05-15 | Shin-Ichi Kanemaru | Base material for regenerating air sinus and regeneration method |
DE102004024635A1 (en) * | 2004-05-12 | 2005-12-08 | Deutsche Gelatine-Fabriken Stoess Ag | Process for the preparation of moldings based on crosslinked gelatin |
US8372433B2 (en) | 2007-01-18 | 2013-02-12 | Gunze Limited | Substrate for culture of cardiovascular tissue |
US9534203B2 (en) | 2007-06-08 | 2017-01-03 | Wake Forest University Health Sciences | Selective cell therapy for the treatment of renal failure |
US9580688B2 (en) | 2007-06-08 | 2017-02-28 | Wake Forest University Health Sciences | Kidney structures and methods of forming the same |
US10590391B2 (en) | 2007-06-08 | 2020-03-17 | Wake Forest University Health Sciences | Selective cell therapy for the treatment of renal failure |
US9192629B2 (en) | 2008-11-12 | 2015-11-24 | Regenmedtx, Llc | Isolated renal cells and uses thereof |
US8318484B2 (en) | 2008-11-12 | 2012-11-27 | Tengion, Inc. | Isolated renal cells and uses thereof |
US10105392B2 (en) | 2008-11-12 | 2018-10-23 | Inregen | Isolated renal cells and uses thereof |
US10077442B2 (en) | 2010-05-12 | 2018-09-18 | Inregen | Bioactive renal cells |
US11066666B2 (en) | 2010-05-12 | 2021-07-20 | Inregen | Bioactive renal cells |
US9724367B2 (en) | 2010-11-10 | 2017-08-08 | Regenmed (Cayman) Ltd. | Injectable formulations for organ augmentation |
US11123372B2 (en) | 2016-07-29 | 2021-09-21 | Prokidney | Bioactive renal cells for the treatment of chronic kidney disease |
US11931383B2 (en) | 2016-07-29 | 2024-03-19 | Prokidney | Bioactive renal cells for the treatment of chronic kidney disease |
Also Published As
Publication number | Publication date |
---|---|
EP0831861A1 (en) | 1998-04-01 |
US6140039A (en) | 2000-10-31 |
KR19990022304A (en) | 1999-03-25 |
JPH11506611A (en) | 1999-06-15 |
AU6031596A (en) | 1996-12-30 |
CA2224071A1 (en) | 1996-12-19 |
NZ310004A (en) | 1999-10-28 |
EP0831861A4 (en) | 2001-11-14 |
US6022743A (en) | 2000-02-08 |
AU706426B2 (en) | 1999-06-17 |
US5863531A (en) | 1999-01-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5863531A (en) | In vitro preparation of tubular tissue structures by stromal cell culture on a three-dimensional framework | |
AU689605B2 (en) | Three-dimensional cartilage cultures | |
AU700911B2 (en) | Three-dimensional human cell cultures on cardiac valve frameworks and their uses | |
Atala | Regenerative medicine strategies | |
DE60028616T2 (en) | METHODS AND COMPOSITIONS FOR THE RECONSTRUCTION OF MULTILAYER TISSUE STRUCTURES | |
AU715282B2 (en) | Method for making and/or repairing cartilage | |
AU770887B2 (en) | Reconstructing organs from decellularized biomaterial scaffold | |
US7998735B2 (en) | Vascularized tissue graft | |
Cortesini | Stem cells, tissue engineering and organogenesis in transplantation | |
US20080026461A1 (en) | Tissue-like organization of cells and macroscopic tissue-like constructs, generated by macromass culture of cells and the method of macromass culture | |
AU4456400A (en) | Three-dimensional stromal tissue | |
AU2171900A (en) | Application of shear flow stress to smooth muscle cells for the production of implantable structures | |
Nasseri et al. | Tissue engineering: an evolving 21st-century science to provide biologic replacement for reconstruction and transplantation | |
Metwalli et al. | Tissue engineering in urology: where are we going? | |
AU729774B2 (en) | Stromal cell-based three-dimensional culture system for forming tubes, tendons, ligaments and corrective structures | |
AU724572B2 (en) | Three-dimensional human cell cultures on cardiac valve frameworks and their uses |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AU CA JP KR NZ |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1019970708783 Country of ref document: KR |
|
ENP | Entry into the national phase |
Ref document number: 1997 501032 Country of ref document: JP Kind code of ref document: A Ref document number: 2224071 Country of ref document: CA Kind code of ref document: A Ref document number: 2224071 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 310004 Country of ref document: NZ Ref document number: 1996917936 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1996917936 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1019970708783 Country of ref document: KR |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1019970708783 Country of ref document: KR |
|
WWR | Wipo information: refused in national office |
Ref document number: 1996917936 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1996917936 Country of ref document: EP |